Jaclyn Heuer, NP
Adult Health · Emerson, NJNPI 1215256516
Payments from drug & device makers
Across 64 payments — averaging $18.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$213
- Amgen$164
- AstraZeneca$118
- Novartis$85
- Pfizer$83
- Boehringer Ingelheim$75
- plus $478 from 16 others
What the payments were for
- Food & beverage$1,215100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 11 | $213 |
| Amgen | 9 | $164 |
| AstraZeneca | 8 | $118 |
| Novartis | 5 | $85 |
| Pfizer | 4 | $83 |
| Boehringer Ingelheim | 3 | $75 |
| Amarin Pharma, Inc. | 3 | $56 |
| Lilly USA, LLC | 3 | $56 |
| GSK | 3 | $48 |
| Johnson & Johnson | 2 | $40 |
| Treace Medical Concepts, Inc. | 1 | $37 |
| Bayer | 1 | $34 |
| G Medical Diagnostic Services, Inc. | 2 | $32 |
| Exact Sciences | 1 | $29 |
| Abbott | 1 | $21 |
| Blueprint Medicines Corporation | 1 | $21 |
| Biocon Biologics Inc | 1 | $19 |
| AbbVie | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| Mallinckrodt Hospital Products Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Radius Health, Inc. | 1 | $15 |
How this compares
$1,215 in reported general payments places this provider in the 70th percentile of 1,135 adult health providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Escitalopram Oxalate | 16 | $410 |
| Rosuvastatin Calcium | 22 | $343 |
| Atorvastatin Calcium | 39 | $330 |
| Levothyroxine Sodium | 17 | $234 |
| Amlodipine Besylate | 27 | $214 |
| Diclofenac Sodium | 22 | $193 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 24 | $190 |
| Simvastatin | 15 | $161 |
| Losartan Potassium | 24 | $132 |
| Azithromycin | 22 | $106 |
| Mometasone Furoate | 13 | $80 |
| Methylprednisolone | 14 | $56 |
| Tramadol Hcl | 12 | $26 |
| Alprazolam | 11 | $9 |
Paid to pharmacies, not to this prescriber.
Other adult health in Emerson
- June HalperHackensack$458K
- Kara SaggiomoCamden$127K
- Entela AhmetiPomona$75K
- Phyllis McKiernanHackensack$72K
- Denise ForceMiddletown$71K
- Kathleen SenecaHillsborough$64K
- Diane AndresenNorthvale$60K
- Dana BeenstockFreehold$51K
- Phyllis DudaCamden$46K
- Anthony WalkoWestwood$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.